T. DeFor

发表

Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non‐malignant diseases

J. Neglia, T. O'Brien, T. Eastlund, 2004, British journal of haematology.

Alternative donor hematopoietic cell transplantation for Fanconi anemia.

J. Wagner, K. Dusenbery, M. MacMillan, 2015, Blood.

T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.

J. Dipersio, D. Porter, S. Farag, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, M. Verneris, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006, Blood.

Infusion reactions in natural killer cell immunotherapy: a retrospective review.

T. Mamo, Jeffrey S. Miller, D. McKenna, 2021, Cytotherapy.

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.

T. Waldmann, G. Vercellotti, Jeffrey S. Miller, 2019, Blood advances.

Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial

J. Wagner, M. MacMillan, B. Blazar, 2009, Bone Marrow Transplantation.

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

C. Le, J. Wagner, Jeffrey S. Miller, 2005, Blood.

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

C. Verfaillie, S. Davies, D. Weisdorf, 1996, Blood.

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.

D. Kaufman, J. Wagner, K. Dusenbery, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Bone Marrow Transplantation.

Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT)

J. Tolar, P. Orchard, P. Jacobson, 2008, Journal of clinical pharmacology.

Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplant Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors

D. Vallera, T. DeFor, A. Borgatti, 2017, Oncotarget.

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndromes Patients ≥70 Years Old

M. Arora, N. Bejanyan, T. DeFor, 2016 .

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.

D. Weisdorf, M. Arora, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402

G. Vercellotti, M. MacMillan, Juan Wu, 2017, Bone Marrow Transplantation.

Matching at HLA-C improved the outcomes after double umbilical cord blood transplantation for recipients of 2–4/6 HLA-matched grafts

J. Wagner, K. Ballen, R. Soiffer, 2017 .

A refined risk score for acute GVHD that predicts response to initial therapy, survival and transplant-related mortality

M. Robin, M. Pasquini, Richard J. Jones, 2015 .

Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802 Biol Blood Marrow Transplant .

Gabrielle, Meyers, G. Vercellotti, 2015 .

Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma

D. Weisdorf, V. Bachanova, J. Miller, 2009, Bone Marrow Transplantation.

Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells

Jeffrey S. Miller, D. Weisdorf, A. Panoskaltsis-Mortari, 2018, Cancer Immunology, Immunotherapy.

High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.

H. Lazarus, T. DeFor, N. Majhail, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous stem cell transplantation for high-risk pediatric solid tumors

J. Neglia, J. Perentesis, T. DeFor, 1999, Bone Marrow Transplantation.

History of Pulmonary Complications in hildren after Bone Marrow Transplantation

D. Cornfield, I. Y. Haddad, B. Blazar, 2004 .

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.

D. Weisdorf, J. Miller, T. Repka, 2000, Experimental hematology.

Risk of Relapse (REL) after Umbilical Cord Blood Transplantation (UCBT) in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2005 .

Neurological Consequences of Cytokine Release Syndrome Following Subcutaneous Recombinant IL-15 and Haploidentical Donor Natural Killer Cell Therapy for Advanced Acute Myeloid Leukemia

T. Waldmann, G. Vercellotti, Jeffrey S. Miller, 2017 .

Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.

P. Orchard, T. DeFor, T. Lund, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation

Michael J. Thrall, W. Krivit, P. Jacobson, 2001, Bone Marrow Transplantation.

Left Ventricular Ejection Fraction Screening and Clinical Decision-making in Metastatic HER2-positive Breast Cancer.

A. Blaes, T. DeFor, S. Konety, 2017, Anticancer research.

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2021, Blood advances.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

J Wagner, J. Wagner, C. Eide, 2002, Blood.

Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types

D. Weisdorf, A. Rashidi, C. Ryan, 2020, ESMO Open.

Successful Remission Rates and Survival after Lymphodepleting Chemotherapy for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2014 .

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2020, Bone Marrow Transplantation.

Interleukin‐1 genotype and outcome of unrelated donor bone marrow transplantation

M. MacMillan, S. Davies, D. Weisdorf, 2003, British journal of haematology.

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2009, Blood.

Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.

A. Khoruts, M. MacMillan, D. Weisdorf, 2019, JCI insight.

Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen.

R. Corvò, G. Storme, K. Dusenbery, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bone marrow transplant with post‐transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts

J. Wagner, J. Tolar, J. McGrath, 2019, The British journal of dermatology.

with umbilical cord blood: safety profile and detection kinetics Infusion of ex vivo expanded T regulatory cells in adults transplanted

J. Wagner, B. Levine, C. June, 2011 .

Highly Variable Mycophenolate Mofetil Bioavailability Following Nonmyeloablative Hematopoietic Cell Transplantation

D. Weisdorf, P. Jacobson, T. DeFor, 2007, Journal of clinical pharmacology.

Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: A comparative clinical analysis

J. Wagner, M. MacMillan, B. Hirsch, 2007, American journal of hematology.

GST genotype may modify clinical phenotype in patients with Fanconi anaemia

S. Batish, A. Auerbach, O. Levran, 2005, British journal of haematology.

preparative regimen for advanced Hodgkin lymphoma donor hematopoietic stem cell transplantation after reduced-intensity Comparable results of umbilical cord blood and HLA-matched sibling

J. Wagner, D. Weisdorf, T. DeFor, 2013 .

Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma.

J. Wagner, D. Weisdorf, T. DeFor, 2006, Blood.

Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis.

R. Parkkola, P. Armand, M. Itälä-Remes, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).

D. Weisdorf, B. Blazar, J. Ferrara, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).

T. Braun, D. Weisdorf, B. Blazar, 2006, Blood.

Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.

J. Wagner, M. Linden, M. Verneris, 2021, Transplantation and Cellular Therapy.

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

B. Wood, C. Hourigan, M. Linden, 2017, Haematologica.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Bin Zhang, Jeffrey S. Miller, D. Weisdorf, 2014, Blood.

J. Wagner, S. Davies, D. Weisdorf, 1997, British journal of haematology.

A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.

P. Orchard, T. DeFor, N. Ramsay, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

M. Linden, M. Burke, J. Miller, 2013, Bone Marrow Transplantation.

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.

P. Parham, J. Wagner, Jeffrey S. Miller, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adaptive NK cell and KIR-expressing T cell responses are induced by CMV and are associated with protection against CMV reactivation after allogeneic donor hematopoietic cell transplantation Blood Marrow Transplant .

P. Parham, J. Wagner, D. Weisdorf, 2015 .

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality.

D. Weisdorf, B. Blazar, T. DeFor, 2020, Blood advances.

Prediction of outcomes after second-line treatment for acute graft-versus-host disease

M. Sorror, M. MacMillan, T. Gooley, 2022, Blood advances.

Outcomes and predictors of response in steroid-refractory acute graft-versus-host disease: single-center results from a cohort of 203 patients.

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease.

B. Blazar, A. Filipovich, T. DeFor, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of continuous versus intermittent infusion cyclosporine and impact on transplant related outcomes in allogeneic transplant recipients

A. Rashidi, T. DeFor, J. Rogosheske, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

New classification of chronic GVHD: added clarity from the consensus diagnoses

J. Witte, M. MacMillan, D. Weisdorf, 2009, Bone Marrow Transplantation.

A Phase I/II Randomized, Placebo-Control Trial of Palifermin to Prevent Graft-Versus- Host Disease (GVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Running head: Palifermin to prevent GVHD

T. Braun, D. Weisdorf, B. Blazar, 2006 .

Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation.

J. Wagner, J. Steinberger, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation

J. Wagner, C. Eide, D. Weisdorf, 2013, Leukemia.

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy.

J. L. Goodman, M. MacMillan, D. Weisdorf, 2002, The American journal of medicine.

Follistatin and Soluble Endoglin Predict 1-year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant.

Jeffrey S. Miller, M. MacMillan, Juan Wu, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.

J. Wagner, Xiyan Xu, Jeffrey S. Miller, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation

M. MacMillan, S. Davies, W. Kiffmeyer, 2003, Transplantation.

Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.

A. Moser, G. Raymond, W. Hubbard, 2014, Molecular genetics and metabolism.

graft-versus-leukemia effect in recipients of 2 units Relapse risk after umbilical cord blood transplantation: enhanced

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2013 .

Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment

D. Yee, D. Duprez, D. Potter, 2015, SpringerPlus.

Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation.

Robin R. Shields-Cutler, Gabriel A. Al-Ghalith, D. Knights, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The worldwide hematopoietic cell transplantation experience for cerebral x-adrenoleukodystrophy

K. Dusenbery, L. Lockman, W. Krivit, 2000 .

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

D. Kaufman, J. Wagner, K. Dusenbery, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.

H. Moser, K. Dusenbery, S. Kato, 2004, Blood.

Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning

J. Wagner, M. Verneris, R. Phelan, 2016, Bone Marrow Transplantation.

Response to thalidomide therapy in refractory chronic graft-versus-host disease

J. Wagner, S. Davies, D. Weisdorf, 2000, Bone Marrow Transplantation.

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units

J. Wagner, D. Weisdorf, J. Miller, 2009, Bone Marrow Transplantation.

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2003, Blood.

Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients.

D. Weisdorf, T. DeFor, J. V. van Burik, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival

M. Steinbuch, D. Weisdorf, A. Filipovich, 1997, Annals of Hematology.

Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2017, Bone Marrow Transplantation.

Iron-overload after autologous hematopoietic cell transplantation.

H. Lazarus, T. DeFor, N. Majhail, 2009, Leukemia research.

Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study

J. Wagner, J. Tolar, M. MacMillan, 2009 .

Alternate Donor HSCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study.

J. Wagner, J. Tolar, M. MacMillan, 2007 .

Thymic Shielding (TS) in Recipients of Total Body Irradiation (TBI) and Alternative Donor Hematopoietic Stem Cell Transplant (AD-HSCT): Reduced Risk of Opportunistic Infection in Patients with Fanconi Anemia (FA).

J. Wagner, K. Dusenbery, M. MacMillan, 2006 .

Successful engraftment without radiation after fludarabine‐based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation

J. Wagner, A. Auerbach, M. MacMillan, 2006, Pediatric blood & cancer.

Hematopoietic Cell and Solid Organ Transplantation in the same patient: Long term experience at the University of Minnesota: Combined Hematopoietic and Solid Organ Transplantation.

T. Pruett, D. Weisdorf, T. DeFor, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.

D. Kaufman, D. Weisdorf, T. DeFor, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

J. Wagner, B. Levine, C. June, 2011, Blood.

Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

G. Vercellotti, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients

S. Bhatia, D. Weisdorf, M. Arora, 2022, Bone Marrow Transplantation.

Hematopoietic Cell Transplant Related Toxicities and Mortality in Frail Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.

S. Davies, D. Weisdorf, B. Blazar, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source.

J. Wagner, R. Hough, M. MacMillan, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic graft-versus-host disease: a prospective cohort study.

M. MacMillan, S. Davies, D. Weisdorf, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.

J. Wagner, C. Verfaillie, Jeffrey S. Miller, 2001, The American journal of medicine.

CMV antigenemia following bone marrow transplantation: risk factors and outcomes.

R. Osarogiagbon, D. Weisdorf, A. Erice, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

J. Wagner, J. Tolar, D. Weisdorf, 2006, Blood.

Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.

J. Wagner, J. Kurtzberg, M. Trigg, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

J. Wagner, S. Davies, D. Weisdorf, 2001, Blood.

Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation.

J. Bidwell, S. Davies, T. DeFor, 2004, Blood.

New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.

L. Robison, J. Neglia, T. DeFor, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.

Daniel J Weisdorf, D. Weisdorf, T. DeFor, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Natural history of pulmonary complications in children after bone marrow transplantation.

D. Cornfield, I. Y. Haddad, B. Blazar, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.

Todd E DeFor, Daniel J Weisdorf, John E Wagner, 2005, Blood.

Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.

Todd E DeFor, Daniel J Weisdorf, John E Wagner, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

J. Wagner, M. MacMillan, D. Weisdorf, 2009, Blood.

Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, T. DeFor, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Blood.

Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type

D. Weisdorf, C. Cohn, T. DeFor, 2021, Transfusion.

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.

A. Fischer, J. Tolar, J. Kurtzberg, 2013, Blood.

Evaluation of post‐thaw CFU‐GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant

J. Wagner, D. Sumstad, D. McKenna, 2019, Transfusion.

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.

J. Wagner, P. Westervelt, J. Dipersio, 2018, Blood.

CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT

J. Wagner, Bin Zhang, Jeffrey S. Miller, 2015, Leukemia.

Elevations in serum alpha fetoprotein levels in patients with Fanconi anaemia

J. Wagner, M. MacMillan, R. Mitchell, 2019, British journal of haematology.

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.

G. Raymond, J. Tolar, J. Eisengart, 2011, Blood.

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

M. Linden, M. Burke, J. Miller, 2013, Bone Marrow Transplantation.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

D. Weisdorf, T. DeFor, A. Cioc, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia

W. Woods, B. Bostrom, B. Blazar, 2000, Bone Marrow Transplantation.

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.

Daniel J Weisdorf, John E Wagner, J. Wagner, 2002, Blood.

Reduced Relapse and Similar Progression-Free Survival After Double Umbilical Cord Blood Transplantation (DUCBT): Comparison of Outcomes Between Sibling, Unrelated Adult and Unrelated DUCB Hematopoietic Stem Cell (HSC) Donors.

J. Wagner, F. Appelbaum, T. Gooley, 2009 .

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)

Jeffrey S. Miller, V. Bachanova, Z. Cayci, 2019, Blood.

cohort report childhood cerebral adrenoleukodystrophy: the largest single-institution Outcomes after allogeneic hematopoietic cell transplantation for

S. Richard, G. Raymond, J. Tolar, 2011 .

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Colleen Delaney, Claudio G Brunstein, Daniel J Weisdorf, 2010, Blood.

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2008, Blood.

Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms.

J. Wagner, M. Sanz, J. Sanz, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.

D. Weisdorf, W. Thomas, T. DeFor, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes.

D. Weisdorf, A. Dudek, T. DeFor, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.

C. Le, J. Wagner, B. Levine, 2016, Blood.

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.

Jakub Tolar, Todd E DeFor, Claudio G Brunstein, 2016, Cell stem cell.

Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2015, Blood.

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.

J. Wagner, M. MacMillan, S. Davies, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.

J. Wagner, M. MacMillan, S. Davies, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.

J. Wagner, M. MacMillan, B. Hirsch, 2010, American journal of clinical pathology.

Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial

J. Wagner, K. Dusenbery, M. MacMillan, 2000, British journal of haematology.

Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.

J. Wagner, M. MacMillan, M. Verneris, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

J Wagner, M. Steinbuch, T. DeFor, 1999, Bone Marrow Transplantation.

Anti-HLA antibodies in double umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, H. Noreen, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors Predicting Single-Unit Predominance after Double Umbilical Cord Blood Transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2011, Bone Marrow Transplantation.

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.

Jeffrey S. Miller, D. Weisdorf, M. Arora, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes.

J. Wagner, J. Tolar, K. Robien, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pediatric acute GVHD: clinical phenotype and response to upfront steroids

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Bone Marrow Transplantation.

Validation of Minnesota acute graft-versus-host disease Risk Score

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Haematologica.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Therapeutic Cyclosporine Levels Early Post-Transplantation Reduces Risks of Acute Graft-Versus-Host Disease and Improves Survival

D. Weisdorf, B. Blazar, M. Arora, 2013, Bone Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

J. Wagner, Priya Kumar, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

M. Robin, M. Pasquini, Richard J. Jones, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

What predicts high risk acute graft‐versus‐host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score

M. MacMillan, D. Weisdorf, T. DeFor, 2012, British journal of haematology.

Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid

A. Khoruts, C. Forster, M. MacMillan, 2018, Modern Pathology.

The best endpoint for acute GVHD treatment trials.

M. MacMillan, D. Weisdorf, T. DeFor, 2010, Blood.

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts.

J. Wagner, K. Ballen, R. Soiffer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2010 .

The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML

J. Wagner, D. Weisdorf, T. DeFor, 2014, Bone Marrow Transplantation.

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes.

M. MacMillan, D. Weisdorf, M. Arora, 2021, Blood advances.

Determinants of survival after human leucocyte antigen‐matched unrelated donor bone marrow transplantation in adults

Jeffrey S. Miller, S. Davies, D. Weisdorf, 2002, British journal of haematology.

bone marrow : results of a matched-pair analysis matched unrelated donor − comparable to that of human leukocyte antigen Survival after transplantation of unrelated donor umbilical cord blood

J. Wagner, S. Davies, D. Weisdorf, 2001 .

Patient interleukin‐18 GCG haplotype associates with improved survival and decreased transplant‐related mortality after unrelated‐donor bone marrow transplantation

J. Bidwell, M. MacMillan, D. Weisdorf, 2004, British journal of haematology.

Complement fragment 3a priming of umbilical cord blood progenitors: safety profile.

J. Wagner, M. Ratajczak, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effects of Priming Regimen and Marrow or Blood Origin of Stem Cells Comparative Analysis of Autografting in Chronic Myelogenous Leukemia

C. Verfaillie, Jeffrey S. Miller, M. Steinbuch, 2010 .

Comparative Analysis of Autografting in Chronic Myelogenous Leukemia: Effects of Priming Regimen and Marrow or Blood Origin of Stem Cells

C. Verfaillie, Jeffrey S. Miller, M. Steinbuch, 1998 .

Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.

C. Verfaillie, M. Steinbuch, B. Hirsch, 1998, Blood.

Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.

C. Le, J. Wagner, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

6: Risk of Relapse after Umbilical Cord Blood Transplantation in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006 .

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

C. Le, K. Dusenbery, Jeffrey S. Miller, 2006 .

Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients.

R. Krance, M. MacMillan, S. Davies, 2011, Blood.

Late outcomes after bone marrow transplant for aplastic anaemia.

L. Robison, A. Mertens, S. Davies, 2000 .

Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.

J. Wagner, C. Ebens, M. MacMillan, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation

J. Wagner, C. Verfaillie, K. Dusenbery, 2000, Bone Marrow Transplantation.

Peritransplant palifermin use and lymphocyte recovery after T‐cell replete, matched related allogeneic hematopoietic cell transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2011, American journal of hematology.

Stress responses , M 2 macrophages , and a distinct microbial signature in fatal intestinal acute graft-versus-host disease

A. Khoruts, M. MacMillan, D. Weisdorf, 2019 .

cells is improved using IL-2 diphtheria toxin fusion protein Clearance of acute myeloid leukemia by haploidentical natural killer

Bin Zhang, D. Weisdorf, B. Blazar, 2014 .

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

W. Wood, J. Pidala, E. Holler, 2018, Blood advances.

Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

M. Linden, D. Weisdorf, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

BRAF Mutation Is Associated with Improved Local Control of Melanoma Brain Metastases Treated with Gamma Knife Radiosurgery

Jianlin Yuan, K. Dusenbery, Yoichi Watanabe, 2016, Front. Oncol..

APOLLO: A phase I study of adaptive memory natural killer (NK) cells in recurrent ovarian cancer.

M. Wallet, Jeffrey S. Miller, D. Teoh, 2020 .

New M alignancies A fter B lood o r M arrow S tem-Cell Transplantation i n C hildren a nd A dults: Incidence a nd R isk F actors

L. Robison, J. Neglia, T. DeFor, 2003 .

Influence of Total Body Irradiation Dose Rate on Idiopathic Pneumonia Syndrome in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

K. Dusenbery, D. Weisdorf, T. DeFor, 2019, International journal of radiation oncology, biology, physics.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diagnostic endoscopy in children after hematopoietic stem cell transplantation.

J. Jessurun, S. Schwarzenberg, R. Nagarajan, 2006, Gastrointestinal endoscopy.

Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.

Jeffrey S. Miller, E. Chiorean, D. Weisdorf, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor‐derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response

J. Wagner, T. DeFor, A. Dietz, 2014, British journal of haematology.

Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

K. Dusenbery, D. Weisdorf, M. Verneris, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late outcomes after bone marrow transplant for aplastic anaemia

L. Robison, A. Mertens, S. Davies, 2000, British journal of haematology.

Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation

J. Wagner, P. Jacobson, T. DeFor, 2009, Bone Marrow Transplantation.

A randomized trial of the effect of a walking regimen on the functional status of 100 adult allogeneic donor hematopoietic cell transplant patients.

D. Weisdorf, T. DeFor, L. Burns, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.

D. Weisdorf, M. Verneris, V. Bachanova, 2009, Blood.

Pericardial effusion after pediatric hematopoietic cell transplant

J. Steinberger, J. Tolar, M. Verneris, 2013, Pediatric transplantation.

Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

M. Linden, A. Rashidi, J. Miller, 2018, Bone Marrow Transplantation.

Impact of Frailty on Hematopoietic Cell on Early Transplant Outcomes in Older Recipients

S. Bhatia, D. Weisdorf, M. Arora, 2015 .

Prolonged subcutaneous administration of 852A, a novel systemic toll‐like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2012, American journal of hematology.

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

S. Bhatia, G. Vercellotti, M. MacMillan, 2021, Blood Cancer Journal.

New Classification of Chronic Graft Versus Host Disease: Added Clarity from the Consensus Diagnoses.

M. MacMillan, D. Weisdorf, M. Arora, 2007 .

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

K. Dusenbery, G. Vercellotti, Jeffrey S. Miller, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.

D. Weisdorf, T. DeFor, Z. Sachs, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease‐negative first complete remission

Kiran R. Vij, M. Linden, D. Weisdorf, 2018, American journal of hematology.

History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease‐negative first complete remission

M. Linden, D. Weisdorf, A. Rashidi, 2017, American journal of hematology.

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial

J. Wagner, D. Douek, M. MacMillan, 2007, Bone Marrow Transplantation.

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Journal of cutaneous pathology.

Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content.

T. DeFor, N. Majhail, S. Cooley, 2013, Blood.

measured liver iron content − transplantation outcomes : a prospective cohort study using R 2-MRI Association of iron overload with allogeneic hematopoietic cell

T. DeFor, N. Majhail, S. Cooley, 2013 .

transplantation reduced-intensity conditioning with cord blood or sibling donor Prolonged survival in adults with acute lymphoblastic leukemia after

D. Weisdorf, M. Verneris, V. Bachanova, 2013 .

Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantation.

P. Hari, D. Vesole, C. Bredeson, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Bone Marrow Transplantation.

Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting

R. Vogel, D. Weisdorf, V. Bachanova, 2012, British journal of haematology.

enhance engraftment in adults with hematologic malignancy Transplantation of two partially HLA-matched umbilical cord blood units to

J. Wagner, C. Verfaillie, D. Weisdorf, 2009 .

Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced intensity conditioning umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

W. Wood, J. Pidala, E. Holler, 2017 .

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

M. Robin, M. MacMillan, D. Weisdorf, 2016, Haematologica.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Avis J. Thomas, J. Wagner, J. Tolar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A multicenter phase 2 clinical trial of 10-day decitabine, dose-escalated donor lymphocyte infusion, and ruxolitinib for relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic cell transplantation.

J. Dipersio, D. Weisdorf, A. Rashidi, 2023, Transplantation and cellular therapy.

Late-onset Acute and Chronic Graft-Versus-Host Disease in Children: Clinical features and Response to Therapy.

M. MacMillan, D. Weisdorf, M. Arora, 2021, Transplantation and cellular therapy.

Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia

J. Wagner, M. MacMillan, B. Hirsch, 2014, British journal of haematology.

Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?

Jeffrey S. Miller, S. Devine, D. Weisdorf, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer (NK) Cells in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma

Jeffrey S. Miller, V. Bachanova, Z. Cayci, 2020, Blood.

A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia

D. Weisdorf, A. Rashidi, N. Bejanyan, 2018, Leukemia & lymphoma.

A modified comorbidity index for hematopoietic cell transplantation

C. Le, D. Weisdorf, M. Arora, 2010, Bone Marrow Transplantation.

Metabolic Syndrome and Cardiovascular Risk Factors after Hematopoietic Cell Transplantation in Severe Mucopolysaccharidosis Type I (Hurler Syndrome).

J. Steinberger, A. Kelly, P. Orchard, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database.

B. Whitson, T. Tuttle, B. Virnig, 2010, The Journal of thoracic and cardiovascular surgery.

Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome

D. Weisdorf, T. DeFor, Z. Sachs, 2016, Bone Marrow Transplantation.

Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation

Robin R. Shields-Cutler, D. Knights, D. Weisdorf, 2019, PloS one.

Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402

D. Weisdorf, B. Blazar, M. Verneris, 2017, Bone Marrow Transplantation.

Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?

T. DeFor, K. Swenson, B. Susnik, 2018, Journal of surgical oncology.